LT . Christina Jamros, DO (Associate. ) . CDR . Ryan Maves, MD (Fellow. ) . CAPT . Mary . Bavaro. , MD (Fellow). Department of Internal . Medicine. Naval . Medical Center, San Diego, CA. Disclosure. I have no relevant financial relationships with any commercial supporters..
Download Presentation - The PPT/PDF document "TREATMENT OF MULTIDRUG-RESISTANT ACINETO..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
TREATMENT OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANII OSTEOMYELITIS WITH ADJUNCTIVE CONTINUOUS CO
Presentation on theme: "TREATMENT OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANII OSTEOMYELITIS WITH ADJUNCTIVE CONTINUOUS CO"— Presentation transcript:
TREATMENT OF MULTIDRUG-RESISTANT ACINETOBACTER BAUMANII OSTEOMYELITIS WITH ADJUNCTIVE CONTINUOUS CO - Description
LT Christina Jamros DO Associate CDR Ryan Maves MD Fellow CAPT Mary Bavaro MD Fellow Department of Internal Medicine Naval Medical Center San Diego CA Disclosure I have no relevant financial relationships with any commercial supporters ID: 689805 Download Presentation
The TB situation in 2013. :. Findings from the joint TB surveillance and monitoring report by . ECDC . and . the WHO Regional Office for Europe . ECDC TB Team. European Centre for Disease Prevention and Control.
Prevention of spread and c ontrol of MD s in health care setting are critical and urgent as the number of antibiotic available to treat these infections is extremely limited and development of new antibiotics is not forthcoming in the foreseeable fu
Mario Vaneechoutte. Laboratory Bacteriology Research. University of Ghent. Flanders, Belgium. Boerhaave . Course. . January 16. th. , 2009. Leiden, the Netherlands. Slides available at: http://users.ugent.be/~mvaneech/LBR.htm.
.. PRESENTERS:. MOHAMED M. NOORANY- . MBChB. V (MUSOM). MUKOYA AQUINATA (. Sr. )- . MBChB. V (MUSOM). FACILITATORS:. DR. JAMES OBONDI (Chief Orthopedic Specialist). DR. STEVE OKELLO (. MBChB. , MMED registrar- .
Schizophrenia. Treatment-Resistant Schizophrenia. Definition of TRS. TRRIP Working Group Consensus. Pathophysiology of TRS. Economic Burden of TRS Healthcare Expenditures. Clinical Burden of TRS. Diagnosis of TRS.
ABSTRACT Abstract Suppurative osteomyelitis is an inflammatory disease of the bone marrow, cortical bone or periosteum caused by bacterial infection. Even presently with the development of antibiotics, some cases become refractory from multi resistant bacteria. The first clinical report using HBOT against osteomyelitis was done by Slack in 1965. Presently, HBOT has become a standard/recommendatory treatment for osteomyelitis in many countries and hyperbaric medicine societies.
Dr Francesca Conradie . Treatment of Drug sensitive TB. 6 months of treatment consisting of . Intensive phase- INH, Rif, PZA and Ethambutol for 2 months. Continuation phase- INH and Rif. Medications are co-formulated.